東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Natural product-based synthetic drug...

Sharma, Abha.

Linked to FindBook

Google Book

Amazon

博客來

Natural product-based synthetic drug molecules in Alzheimer's disease = therapeutic & theranostic agents /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Natural product-based synthetic drug molecules in Alzheimer's disease/ edited by Abha Sharma, Gyan Prakash Modi.
Reminder of title:	therapeutic & theranostic agents /
other author:	Sharma, Abha.
Published:	Singapore :Springer Nature Singapore : : 2023.,
Description:	xiii, 447 p. :ill., digital ;24 cm.
[NT 15003449]:	Section 1: Introduction of Alzheimer's Disease -- Chapter 1: Alzheimer's disease and drug targets -- Chapter 2: Oxidative stress and metals in Alzheimer's disease -- Chapter 3: Neuroinflammation in Alzheimer's disease -- Section 2: Biomarkers and Diagnosis in Alzheimer's Disease -- Chapter 4: Biomarkers of Alzheimer's disease -- Chapter 5: Naturally inspired fluorescent organic molecules as diagnostic and theranostic tools in Alzheimer's disease -- Chapter 6: Nanostructure-based molecules as diagnostic and theranostic tools in AD -- Section 3: Drug derivatives: A strategy for new multifunctional drug development for Alzheimer's Disease -- Chapter 7: Approved cholinesterase inhibitors-based derivatives: Synthesis and their biological evaluation -- Chapter 8: Memantine-based derivatives: Synthesis and their biological evaluation -- Section 4: Natural molecules inspired novel derivatives for Alzheimer's Disease -- Chapter 9: Huperzine-based derivatives: Design, synthesis, and anti-Alzheimer activity -- Chapter 10: Polyphenol: Development of polyphenol-inspired derivatives targeting pathological factors of AD -- Chapter 11: Flavonoid-based derivatives for modulating various targets of Alzheimer's disease -- Chapter 12: Vitamin-based derivatives for the management of Alzheimer's disease -- Section 5: Metal dyshomeostasis: A hypothesis for developing drugs for the treatment of Alzheimer's disease -- Chapter 13: Metal chelators as a potential therapeutic agent for Alzheimer's disease -- Chapter 14: Ferroptosis modulators: A potential therapeutic target in Alzheimer's disease -- Section 6. Natural products/Synthetic molecules as epigenetic modulators in Alzheimer's disease -- Chapter 15. Sirtuin modulator: Design, synthesis, and biological evaluation -- Chapter 16. Histone deacetylase Inhibitors: Design, synthesis, and biological evaluation.
Contained By:	Springer Nature eBook
Subject:	Alzheimer's disease - Treatment. -
Online resource:	https://doi.org/10.1007/978-981-99-6038-5
ISBN:	9789819960385

Natural product-based synthetic drug molecules in Alzheimer's disease = therapeutic & theranostic agents /
Natural product-based synthetic drug molecules in Alzheimer's diseasetherapeutic & theranostic agents /[electronic resource] :edited by Abha Sharma, Gyan Prakash Modi. - Singapore :Springer Nature Singapore :2023. - xiii, 447 p. :ill., digital ;24 cm.

Section 1: Introduction of Alzheimer's Disease -- Chapter 1: Alzheimer's disease and drug targets -- Chapter 2: Oxidative stress and metals in Alzheimer's disease -- Chapter 3: Neuroinflammation in Alzheimer's disease -- Section 2: Biomarkers and Diagnosis in Alzheimer's Disease -- Chapter 4: Biomarkers of Alzheimer's disease -- Chapter 5: Naturally inspired fluorescent organic molecules as diagnostic and theranostic tools in Alzheimer's disease -- Chapter 6: Nanostructure-based molecules as diagnostic and theranostic tools in AD -- Section 3: Drug derivatives: A strategy for new multifunctional drug development for Alzheimer's Disease -- Chapter 7: Approved cholinesterase inhibitors-based derivatives: Synthesis and their biological evaluation -- Chapter 8: Memantine-based derivatives: Synthesis and their biological evaluation -- Section 4: Natural molecules inspired novel derivatives for Alzheimer's Disease -- Chapter 9: Huperzine-based derivatives: Design, synthesis, and anti-Alzheimer activity -- Chapter 10: Polyphenol: Development of polyphenol-inspired derivatives targeting pathological factors of AD -- Chapter 11: Flavonoid-based derivatives for modulating various targets of Alzheimer's disease -- Chapter 12: Vitamin-based derivatives for the management of Alzheimer's disease -- Section 5: Metal dyshomeostasis: A hypothesis for developing drugs for the treatment of Alzheimer's disease -- Chapter 13: Metal chelators as a potential therapeutic agent for Alzheimer's disease -- Chapter 14: Ferroptosis modulators: A potential therapeutic target in Alzheimer's disease -- Section 6. Natural products/Synthetic molecules as epigenetic modulators in Alzheimer's disease -- Chapter 15. Sirtuin modulator: Design, synthesis, and biological evaluation -- Chapter 16. Histone deacetylase Inhibitors: Design, synthesis, and biological evaluation.

This book illustrates the importance of natural products as the source for the development of novel drugs for the treatment of neurodegenerative disorders, including Alzheimer's disease. It also highlights the role of reactive oxygen species and altered metal homeostasis in the progression of Alzheimer's disease and examines the potential of antioxidants and anti-chelating agents in the clinical intervention of neurodegenerative diseases. The book also discusses the role of neuroinflammation in the pathogenesis of Alzheimer's disease. The chapters provide information about the drug targets, progress in the development of natural product-based therapeutics, biomarkers, fluorescent diagnostic tools, and theranostic for Alzheimer's disease. The book also provides information about the design and synthesis of natural product-based derivatives against the various targets of Alzheimer's disease including epigenetic targets and the metal dyshomeostasis hypothesis. Cutting across different disciplines, this book is a valuable source for neuroscientists, chemical biologists, pharmaceutical researchers, and synthetic biologists.

ISBN: 9789819960385

Standard No.: 10.1007/978-981-99-6038-5doiSubjects--Topical Terms:

660535
Alzheimer's disease
--Treatment.

LC Class. No.: RC523

Dewey Class. No.: 616.831061

Natural product-based synthetic drug molecules in Alzheimer's disease = therapeutic & theranostic agents /
LDR:04037nmm a2200325 a 4500 001 2390145
003 DE-He213
005 20231215004212.0
006 m d
007 cr nn 008maaau
008 250916s2023 si s 0 eng d
020 $a 9789819960385 $q (electronic bk.)
020 $a 9789819960378 $q (paper)
024 7 $a 10.1007/978-981-99-6038-5 $2 doi
035 $a 978-981-99-6038-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC523
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
072 7 $a PSAN $2 thema
082 0 4 $a 616.831061 $2 23
090 $a RC523 $b .N285 2023
245 0 0 $a Natural product-based synthetic drug molecules in Alzheimer's disease $h [electronic resource] : $b therapeutic & theranostic agents / $c edited by Abha Sharma, Gyan Prakash Modi.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2023.
300 $a xiii, 447 p. : $b ill., digital ; $c 24 cm.
505 0 $a Section 1: Introduction of Alzheimer's Disease -- Chapter 1: Alzheimer's disease and drug targets -- Chapter 2: Oxidative stress and metals in Alzheimer's disease -- Chapter 3: Neuroinflammation in Alzheimer's disease -- Section 2: Biomarkers and Diagnosis in Alzheimer's Disease -- Chapter 4: Biomarkers of Alzheimer's disease -- Chapter 5: Naturally inspired fluorescent organic molecules as diagnostic and theranostic tools in Alzheimer's disease -- Chapter 6: Nanostructure-based molecules as diagnostic and theranostic tools in AD -- Section 3: Drug derivatives: A strategy for new multifunctional drug development for Alzheimer's Disease -- Chapter 7: Approved cholinesterase inhibitors-based derivatives: Synthesis and their biological evaluation -- Chapter 8: Memantine-based derivatives: Synthesis and their biological evaluation -- Section 4: Natural molecules inspired novel derivatives for Alzheimer's Disease -- Chapter 9: Huperzine-based derivatives: Design, synthesis, and anti-Alzheimer activity -- Chapter 10: Polyphenol: Development of polyphenol-inspired derivatives targeting pathological factors of AD -- Chapter 11: Flavonoid-based derivatives for modulating various targets of Alzheimer's disease -- Chapter 12: Vitamin-based derivatives for the management of Alzheimer's disease -- Section 5: Metal dyshomeostasis: A hypothesis for developing drugs for the treatment of Alzheimer's disease -- Chapter 13: Metal chelators as a potential therapeutic agent for Alzheimer's disease -- Chapter 14: Ferroptosis modulators: A potential therapeutic target in Alzheimer's disease -- Section 6. Natural products/Synthetic molecules as epigenetic modulators in Alzheimer's disease -- Chapter 15. Sirtuin modulator: Design, synthesis, and biological evaluation -- Chapter 16. Histone deacetylase Inhibitors: Design, synthesis, and biological evaluation.
520 $a This book illustrates the importance of natural products as the source for the development of novel drugs for the treatment of neurodegenerative disorders, including Alzheimer's disease. It also highlights the role of reactive oxygen species and altered metal homeostasis in the progression of Alzheimer's disease and examines the potential of antioxidants and anti-chelating agents in the clinical intervention of neurodegenerative diseases. The book also discusses the role of neuroinflammation in the pathogenesis of Alzheimer's disease. The chapters provide information about the drug targets, progress in the development of natural product-based therapeutics, biomarkers, fluorescent diagnostic tools, and theranostic for Alzheimer's disease. The book also provides information about the design and synthesis of natural product-based derivatives against the various targets of Alzheimer's disease including epigenetic targets and the metal dyshomeostasis hypothesis. Cutting across different disciplines, this book is a valuable source for neuroscientists, chemical biologists, pharmaceutical researchers, and synthetic biologists.
650 0 $a Alzheimer's disease $x Treatment. $3 660535
650 0 $a Natural products $x Therapeutic use. $3 768635
650 0 $a Synthetic drugs. $3 3321136
650 1 4 $a Neuropharmacology. $3 588720
650 2 4 $a Pharmacology. $3 634543
650 2 4 $a Neurology. $3 588698
700 1 $a Sharma, Abha. $3 3756349
700 1 $a Modi, Gyan Prakash. $3 3756350
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-99-6038-5
950 $a Medicine (SpringerNature-11650)